Aktie A1H5XJ LOTUS PHARMACEUTICALS, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Lotus Pharmaceuticals, Inc.

Aktien

A1H5XJ

US5457152032

LTUS

Markt geschlossen - OTC Markets
Andere Börsenplätze
 19:26:33 01.07.2024 		% 5 Tage % 1. Jan.
0.0033 USD -15.38% Intraday Chart für Lotus Pharmaceuticals, Inc. -15.38% -23.26%
2023 Amarin und Lotus Pharmaceuticals vereinbaren exklusiven Vertrieb von Vazkepa in 10 asiatischen Ländern MT

Andere Sprachen

Suchen
Ergebnisse ansehen
Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!
100% kostenlose Registrierung
Lotus Pharmaceuticals announces the acquisition of Teva Pharma Thailand, expanding its footprint in Southeast Asia
Lotus Achieves Historic Q3 2023 Results with YTD EPS Soaring to a Record NTD 14.19 Marking a 29% Year-on-Year Growth
Lotus Continued Stelar Growth in 2Q 2023 EPS Recorded NTD 4.85 with 285% Growth Year on Year
Lotus Continued Stelar Growth in 2Q 2023 EPS Recorded NTD 4.85 with 285% Growth Year on Year
AMARIN AND LOTUS PHARMACEUTICALS ANNOUNCE EXCLUSIVE PARTNERSHIP AGREEMENT TO COMMERCIALIZE VAZKEPA IN SOUTHEAST ASIA AND SOUTH KOREA
Amarin, Lotus Pharmaceuticals Agree to Exclusive Vazkepa Distribution Deal in 10 Asian Countries
Lotus Announces MFDS Approval for GRALISE SR, Once-Daily Tablets for Post-Herpetic Neuralgia
Lotus revenues grow by 16% and profit doubles year over year
Lotus acquires Alimta in Taiwan from Lilly
Lotus Pharmaceuticals - Aztiq and Innobic officially become Lotus's majority shareholders
Lotus Reports Solid Performance in First Quarter of 2022
Lotus Pharmaceuticals : Unaudited Financial Statement
Lotus Pharmaceuticals acquires Cialis (Tadalafil) in Taiwan from Lilly
Lotus achieves another record high EPS for FY2021
A powerful investment alliance of Aztiq and Innobic acquires Alvogen's shares in Lotus and Adalvo in a US$475m deal
Thai oil firm PTT expands pharma business with $475 million Alvogen deal
Lotus Pharmaceuticals : Informational Disclosure
Lotus Pharmaceuticals : Unaudited Financial Statements
Lotus Pharmaceuticals : Temasek-backed Vertex expects at least $400 million in new S.E.Asia/India fund
Lotus Pharmaceuticals : PTT invests in Lotus
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A1H5XJ Aktie
  4. Nachrichten Lotus Pharmaceuticals, Inc.
  5. Andere Sprachen